MYB down-regulation enhances sensitivity of U937 myeloid leukemia cells to the histone deacetylase inhibitor LBH589 in vitro and in vivo
Ping Ye(Central Hospital of Wuhan), Thomas J. Gonda(University of South Australia), Crystal McGirr, Liang Zhao(Shanghai Chest Hospital)
Cited by 14
Related Papers
A family of cytokine-inducible inhibitors of signalling
|Nature|1997|2.1k
Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes
|Cell Metabolism|2020|1.7k
MYB function in normal and cancer cells
|Nature reviews. Cancer|2008|627